The decision by AstraZeneca to commit up to $18.5 billion to license weight-loss and metabolic drug candidates from CSPC Pharmaceutical Group marks a decisive shift in how Western drugmakers are sourcing innovation in one of the most competitive therapeutic markets in decades. Far from being a...

Microsoft’s latest earnings cycle has exposed a growing tension at the heart of the artificial-intelligence boom: the gap between unprecedented capital spending and the pace at which that spending converts into visible revenue growth. While the company continues to position itself as a long-term...

Nike’s decision to eliminate 775 jobs in the United States reflects a deliberate recalibration of how the company intends to operate in a slower, more competitive global sportswear market. Rather than treating the layoffs as a one-off response to weak sales, the move signals a deeper strategic...

Procter & Gamble’s latest quarterly performance underscores how shifts in U.S. consumer behavior can ripple through even the most resilient global companies. While the consumer goods giant continues to demonstrate pricing power and strength in premium categories, slower growth in its largest...

Netflix’s defence of its bid for Warner Bros Discovery has become a proxy for a much larger strategic debate unfolding inside the global media industry. The sharp drop in the company’s share price following an otherwise solid earnings report underscored investor unease, but the reasoning Netflix’s...

Burberry’s stronger-than-expected holiday performance marks more than a seasonal rebound for a luxury house emerging from a prolonged industry slowdown. It reflects a strategic recalibration that has aligned heritage, product focus, and localised storytelling with the tastes and behaviours of...

For the world’s largest IKEA retailer, the lesson of the past five years has been clear: shoppers are no longer simply hunting for the lowest possible price, but for reassurance that prices will not swing unpredictably from one season to the next. After a period marked by pandemic shocks, inflation...

A little-known European biotech’s meteoric rise has become a case study in how scientific validation, market timing, and industry pressure can rapidly transform a niche player into a strategic prize. After years of relative anonymity, Abivax vaulted into the spotlight following clinical results...

General Motors’ decision to take a $6 billion writedown tied to its electric vehicle strategy marks a significant inflection point for one of the auto industry’s most ambitious EV adopters. Once positioned as a leader intent on rapidly transitioning away from internal combustion engines, the...

Early-stage talks between Rio Tinto and Glencore have reopened the possibility of one of the most consequential mergers the global mining industry has ever contemplated. A transaction combining the two would create the world’s largest miner by market value, reshaping competitive dynamics across...

Samsung Electronics’ forecast of a threefold jump in quarterly operating profit marks more than a cyclical rebound. It signals a structural shift in the global semiconductor market, where artificial intelligence has rapidly transformed memory chips from a commoditized input into a strategic...